MHC and Multiple Sclerosis

  • M. G. Marrosu
Part of the Topics in Neuroscience book series (TOPNEURO)


The major histocompatibility complex (MHC, also called HLA or human leukocyte antigen) and its products have a central role in the immune response. Sharing of the MHC class II region is important for CD4+ (helper) T cell interactions, and sharing of the MHC class I region is important for CD8+ (cytotoxic) T cell interactions. This phenomenon is called MHC restriction of antigen-specific T cell responses.


Multiple Sclerosis Multiple Scle Polymorphic Residue Pathogenic Peptide Rare Allele Advantage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stern LJ, Brown JH, Jardestzky TS et al. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215–221PubMedCrossRefGoogle Scholar
  2. 2.
    Krieger JI, Karr RW, Grey HM et al. (1991) Single amino acid changes in DR and antigen define residues crucial for peptide-MHC binding and T cell recognition. J Immunol 146: 2331–2338PubMedGoogle Scholar
  3. 3.
    Chicz RM, Urban RG, Gorga JC et al. (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178: 27–47PubMedCrossRefGoogle Scholar
  4. 4.
    Bell JI, Todd JA, McDevitt HO (1989) The molecular basis of HLA disease association. In: Harris H, Hirschorn K (eds) Advances in human genetics. Plenum, London, pp10–17Google Scholar
  5. 5.
    Marsh SGE, Bodmer G (1991) HLA class II nucleotide sequences, 1991. Tissue Antigens 37: 181–189PubMedCrossRefGoogle Scholar
  6. 6.
    Risch N (1987) Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 40: 1–14PubMedGoogle Scholar
  7. 7.
    Thomson G (1995) Mapping disease genes: family-based association studies. Am J Hum Genet 75: 487–498Google Scholar
  8. 8.
    Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am J Hum Genet 52: 506–516PubMedGoogle Scholar
  9. 9.
    Tienari PJ, Terwilliger JD, Ott J et al. (1994) Two-locus linkage analysis in multiple sclerosis (MS). Genomics 19: 320–325PubMedCrossRefGoogle Scholar
  10. 10.
    Hillert J, Olerup O (1993) Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15, DQ6, Dw2 haplotype. Neurology 43: 163–168PubMedCrossRefGoogle Scholar
  11. 11.
    Marrosu MG, Muntoni F, Murru MR et al. (1988) Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology 38:1749–1753PubMedCrossRefGoogle Scholar
  12. 12.
    Marrosu MG, Murru MR, Costa G et al. (1997) Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am J Hum Genet 61: 454–457PubMedCrossRefGoogle Scholar
  13. 13.
    Marrosu MG, Murru MR, Costa G et al. (1998) DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 7: 1235–1237PubMedCrossRefGoogle Scholar
  14. 14.
    Hammer J, Gallazzi F, Bono E et al. (1995) Peptide-binding to HLA-DR4 molecules: Correlation to rheumatoid arthritis association. J Exp Med 181:1847–1855PubMedCrossRefGoogle Scholar
  15. 15.
    Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695–705PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • M. G. Marrosu
    • 1
  1. 1.Neurophysiopathology Section, Department of NeuroscienceUniversity of CagliariCagliariItaly

Personalised recommendations